HUM vs ASMIY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HUM · Humana$433.74 ▲ 5.33%
ASMIY · ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS$720.75 ▲ 4.56%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HUM +83.9%
- ASMIY +15.3%
Head to head
| Metric | HUM | ASMIY |
|---|---|---|
| Price | $433.74 | $720.75 |
| Change today | ▲ 5.33% | ▲ 4.56% |
| Market cap | $52.08B | $52.06B |
| Return, 3 months | +12.5% | -27.0% |
| Return, year to date | +70.6% | +19.9% |
| Return, 1 year | +74.0% | +16.3% |
| P/E (TTM) | 41.0 | 30.5 |
| P/B | 2.7 | 6.7 |
| P/E percentile vs own 5y | 98th | – |
| Dividend yield | 0.82% | 0.53% |
| Revenue growth (YoY, latest qtr) | +26.2% | – |
| Net profit growth (YoY) | +27.6% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 0.9% | – |
| Return on equity | 6.8% | – |
| Analyst target vs. price | +11.4% | – |
| Analyst buy share | 75% | – |
| RSI (14) | 61 | 35 |
| 30-day volatility | 45.3% | 66.4% |
| Max drawdown, 1 year | -44.3% | -44.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HUM is the largest of the group by market value.
- HUM has returned the most over the past year.
- ASMIY carries the lowest trailing P/E.
- HUM pays the highest dividend yield.
- HUM has been the calmest stock over the last 30 days.